IL6R and inflammatory bowel disease: Indeed, increased levels of serum IL-6 and TNF-α are typically detected in IBD patients; and anti-IL-6R antibodies and TNF-α-blocking agents could be powerful therapeutic alternatives for achieving remission in IBD [40, 41].